Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents

European Journal of Medicinal Chemistry

Volumn 54, Issue , 2012, Pages 669-678

  Csuk, René ^a   Albert, Sabrina ^a   Siewert, Bianka ^a   Schwarz, Stefan ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Antitumor activity; Apoptosis; Mizoroki Heck reactions; Stilbenes

Indexed keywords

2',4,4' TRIMETHOXYSTILBENE; 2',4,5' TRIMETHOXYSTILBENE; 2',5' DIHYDROX 3 METHOXYSTILBENE; 2',5' DIHYDROXY 4 METHOXYSTILBENE; 2',5' DIMETHOXY 4 HYDROXYSTILBENE; 3 HYDROXY 2',4,4' TRIMETHOXYSTILBENE; 3 HYDROXY 2',4,5' TRIMETHOXYSTILBENE; 3 HYDROXY 3',4,5' TRIMETHOXYSTILBENE; 3 METHOXY 2',4,5' TRIHYDROXYSTILBENE; 3',4,5' TRIHYDROXYSTILBENE; 3',5' DIMETHOXY 4 HYDROXYSTILBENE; 3',5' DIMETHOXY 4' FLUORO 3 HYDROXYSTILBENE; 3',5' DIMETHOXY 4' FLUORO 4 HYDROXYSTILBENE; 3,3',4,5' TETRAMETHOXYSTILBENE; 3,5 DIMETHOXY 3',4,5' TRIHYDROXYSTILBENE; 4 HYDROXY 2',3,5,5' TETRAMETHOXYSTILBENE; 4 HYDROXY 3',4',5' TRIFLUOROSTILBENE; 4 HYDROXY 3,3',5,5' TETRAMETHOXYSTILBENE; 4 HYDROXY 4' FLUORO 3,3',5' TRIMETHOXYSTILBENE; 4' FLUORO 3 HYDROXY 3',4,5' TRIMETHOXYSTILBENE; 4' FLUORO 3',4,5' TRIMETHOXYSTILBENE; 4' FLUORO 3,3',4,5' TETRAMETHOXYSTILBENE; 4' FLUORO 4 HYDROXY 3,3',5,5' TETRAMETHOXYSTILBENE; ACRIDINE ORANGE; ANTINEOPLASTIC AGENT; COMBRETASTATIN; ETHIDIUM BROMIDE; STILBENE DERIVATIVE; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL; CONTROLLED STUDY; CROSS COUPLING REACTION; CYTOTOXICITY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; FIBROBLAST; HUMAN; HUMAN CELL; IC 50; MIZOROKI HECK COUPLING; MOUSE; NONHUMAN; TUMOR CELL; WITTIG REARRANGEMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CHEMISTRY TECHNIQUES, SYNTHETIC; HUMANS; MICE; NIH 3T3 CELLS; STILBENES;

EID: 84864409871     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.06.015     Document Type: Article

References (62)

1. J. Burns, T. Yokota, H. Ashihara, M.E.J. Lean, and A. Crozier Plant foods and herbal sources of resveratrol J. Agr. Food Chem. 50 2002 3337 3340 (Pubitemid 34533643)
2. J.H. Hart Role of phytostilbenes in decay and disease resistance Annu. Rev. Phytopathol. 19 1981 437 458
3. N. Keskin, T. Noyan, and B. Kunter Health from grape by resveratrol: review Turk. Klin. Tip. Bilim. 29 2009 1273 1279
4. S. Fulda Resveratrol and derivatives for the prevention and treatment of cancer Drug Discov. Today 15 2010 757 765
5. C. Tsang, S. Higgins, G. Duthie, M.E.J. Lean, and A. Crozier The influence of moderate red wine consumption on antioxidant status and on indices of oxidative stress relevant to coronary heart disease in healthy volunteers Free Radic. Res. 36 2002 95 96
6. L. Le Corre, N. Chalabi, L. Delort, Y.J. Bignon, and D.J. Bernard-Gallon Resveratrol and breast cancer chemoprevention: molecular mechanisms Mol. Nutr. Food Res. 49 2005 462 471 (Pubitemid 40780393)
7. M. Larrosa, F.A. Tomas-Barberan, and J.C. Espin The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells Eur. J. Nutr. 43 2004 275 284 (Pubitemid 39377761)
8. G.R. Pettit, and S.B. Singh Antineoplastic agents. 130. Isolation, structure, and synthesis of combretastatin A-2, A-3, and B-2 Can. J. Chem. 65 1987 2390 2396 (Pubitemid 17164506)
9. G.R. Pettit, and J.W. Lippert III Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs Anti-Cancer Drug Des. 15 2000 203 216
10. A. Chaudhary, S.N. Pandeya, P. Kumar, P. Sharma, S. Gupta, N. Soni, K.K. Verma, and G. Bhardwaj Combretastatin a-4 analogs as anticancer agents Mini-Rev. Med. Chem. 7 2007 1186 1205 (Pubitemid 350303084)
11. N.H. Nam Combretastatin A-4 analogues as antimitotic antitumor agents Curr. Med. Chem. 10 2003 1697 1722
12. G.R. Pettit, J.W. Lippert III, D.L. Herald, E. Hamel, and R.K. Pettit Antineoplastic agents 440. Asymmetric synthesis and evaluation of the combretastatin A-1 SAR probes (1S,2S)- and (1R,2R)-1,2-dihydroxy- 1-(2′,3′-dihydroxy-4′-methoxyphenyl)-2-(3′,4′, 5′-trimethoxyphenyl)-ethane J. Nat. Prod. 63 2000 969 974 (Pubitemid 30624483)
13. G.R. Pettit, and J.W. Lippert III Preparation of combretastatin A-1 phosphate and combretastatin B-1 phosphate prodrugs with increased solubility, WO2001081355A1 (2001) Chem. Abs. 2001 798232
14. S.E. Holwell, P.A. Cooper, M.J. Thompson, G.R. Pettit, J.W. Lippert III, S.W. Martin, and M.C. Bibby Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate Anticancer Res. 22 2002 3933 3940 (Pubitemid 36134416)
15. S.D. Shnyder, P.A. Cooper, G.R. Pettit, J.W. Lippert III, and M.C. Bibby Combretastatin A-1 phosphate potentiates the antitumour activity of cisplatin in a murine adenocarcinoma model Anticancer Res. 23 2003 1619 1623 (Pubitemid 36754137)
16. I.G. Kirwan, P.M. Loadman, D.J. Swaine, D.A. Anthoney, G.R. Pettit, J.W. Lippert III, S.D. Shnyder, P.A. Cooper, and M.C. Bibby Comparative preclinical pharmacokinetic and metabolic studies of the combretastatin prodrugs combretastatin A4 phosphate and A1 phosphate Clin. Cancer Res. 10 2004 1446 1453 (Pubitemid 38365240)
17. J.W. Lippert Vascular disrupting agents Bioorg. Med. Chem. 15 2007 605 615
18. R.P. Tanpure, B.L. Nguyen, T.E. Strecker, S. Aguirre, S. Sharma, D.J. Chaplin, B.G. Siim, E. Hamel, J.W. Lippert, G.R. Pettit, M.L. Trawick, and K.G. Pinney Regioselective synthesis of water-soluble monophosphate derivatives of combretastatin A-1 J. Nat. Prod. 74 2011 1568 1574
19. D. Simoni, F.P. Invidiata, M. Eleopra, P. Marchetti, R. Rondanin, R. Baruchello, G. Grisolia, A. Tripathi, G.E. Kellogg, D. Durrant, and R.M. Lee Design, synthesis and biological evaluation of novel stilbene-based antitumor agents Bioorg. Med. Chem. 17 2009 512 522
20. M. Zoldakova, B. Biersack, H. Kostrhunova, A. Ahmad, S. Padhye, F.H. Sarkar, R. Schobert, and V. Brabec (Carboxydiamine)Pt(II) complexes of a combretastatin A-4 analogous chalcone: the influence of the diamine ligand on DNA binding and anticancer effects MedChemComm 2 2011 493 499
21. R. Schobert, K. Effenberger-Neidnicht, and B. Biersack Stable combretastatin A-4 analogues with sub-nanomolar efficacy against chemoresistant HT-29 cells Int. J. Clin. Pharmacol. Ther. 49 2011 71 72
22. J.C. Soria, R. Bahleda, B. Besse, C. Sessa, R.G. Calderone, L. Gianni, G. Del Conte, A. Perotti, B. Daglish, and C. Oprea Phase I study of the vascular disrupting agent (VDA) ombrabulin (Ob) in combination with taxanes (T) and platinum salts (PS) in patients (pts) with advanced solid tumors Ejc Suppl. 8 2010 122 123
23. C.J. Lion, C.S. Matthews, M.F.G. Stevens, and A.D. Westwell Synthesis, antitumor evaluation, and apoptosis-inducing activity of hydroxylated (E)-stilbenes J. Med. Chem. 48 2005 1292 1295 (Pubitemid 40270477)
24. F. Mazue, D. Colin, J. Gobbo, M. Wegner, A. Rescifina, C. Spatafora, D. Fasseur, D. Delmas, P. Meunier, C. Tringali, and N. Latruffe Structural determinants of resveratrol for cell proliferation inhibition potency: experimental and docking studies of new analogs Eur. J. Med. Chem. 45 2010 2972 2980
25. N. Latruffe, F. Mazue, D. Colin, and D. Delmas Characterization of new cell targets to resveratrol a cancer chemopreventive agent Int. J. Mol. Med. 26 2010 S5
26. S. Fulda, and K.M. Debatin Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol Oncogene 23 2004 6702 6711 (Pubitemid 39280002)
27. A.R. Jazirehi, and B. Bonavida Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis Mol. Cancer Ther. 3 2004 71 84 (Pubitemid 39193680)
28. D. Delmas, C. Rebe, O. Micheau, A. Athias, P. Gambert, S. Grazide, G. Laurent, N. Latruffe, and E. Solary Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells Oncogene 23 2004 8979 8986 (Pubitemid 39657788)
29. I. Zoberi, C.M. Bradbury, H.A. Curry, K.S. Bisht, P.C. Goswami, J.L.R. Roti, and D. Gius Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines Cancer Lett. 175 2002 165 173 (Pubitemid 34001714)
30. A. Ianni, and S.R. Waldvogel Reliable and versatile synthesis of 2-aryl-substituted cinnamic acid esters Synthesis 2006 2103 2112 (Pubitemid 44073550)
31. G. Hilt, and C. Hengst A concise synthesis of substituted Stilbenes and Styrenes from propargylic phosphonium salts by a cobalt-catalyzed Diels-Alder/Wittig olefination reaction sequence J. Org. Chem. 72 2007 7337 7342 (Pubitemid 47425503)
32. R. Ketcham, L. Martinelli, and D. Jambotka Preparation of cis-4-nitro-4′-methoxystilbene via Wittig reaction J. Org. Chem. 27 1962 4666
33. W.P. Gallagher, and R.E. Maleczka Stille reactions catalytic in tin: a "Sn-F" route for intermolecular and intramolecular couplings J. Org. Chem. 70 2005 841 846 (Pubitemid 40189495)
34. M. Ephritikhine A new look at the McMurry reaction Chem. Commun. 1998 2549 2554 (Pubitemid 28544838)
35. H.J. Li, and L. Wang Triethanolamine as an efficient and reusable base, ligand and reaction medium for phosphane-free palladium-catalyzed Heck reactions Eur. J. Org. Chem. 2006 5099 5102
36. R. Csuk, and S. Albert A short synthesis of rhaponticin and its 3′-fluoroanalog via a Wittig/Heck-Mizoroki route Z. Naturforsch. B 66 2011 311 316
37. R.F. Heck, and J.P. Nolley Palladium-catalyzed vinylic hydrogen substitution reactions with aryl, benzyl, and styryl halides J. Org. Chem. 37 1972 2320
38. T. Mizoroki, K. Mori, and A. Ozaki Arylation of olefin with aryl iodide catalyzed by palladium Bull. Chem. Soc. Jpn. 44 1971 581
39. S. Albert, R. Horbach, H.B. Deising, B. Siewert, and R. Csuk Synthesis and antimicrobial activity of (E) stilbene derivatives Bioorg. Med. Chem. 19 2011 5155 5166
40. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. Mcmahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenney, and M.R. Boyd New colorimetric cytotoxicity assay for anticancer-drug screening J. Natl. Cancer Inst. 82 1990 1107 1112 (Pubitemid 20213250)
41. G.R. Pettit, M.D. Minardi, H.J. Rosenberg, E. Hamel, M.C. Bibby, S.W. Martin, M.K. Jung, R.K. Pettit, T.J. Cuthbertson, and J.-C. Chapuis Antineoplastic agents. 509. Synthesis of fluorcombstatin phosphate and related 3-halostilbenes J. Nat. Prod. 68 2005 1450 1458 (Pubitemid 41658893)
42. G.R. Pettit, H.J. Rosenberg, and M.D. Minardi Preparation of halocombstatins for use in pharmaceutical compositions for the treatment of cancer, WO2006036743A2 (2006) Chem. Abs. 2006 318869
43. T.J. Liegler, W. Hyun, T.S.B. Yen, and D.P. Stites Detection and quantification of live, apoptotic, and necrotic human peripheral lymphocytes by single-laser flow-cytometry Clin. Diagn. Lab. Immunol. 2 1995 369 376
44. C.M. Davies A comparison of fluorochromes for direct viable counts by image-analysis Lett. Appl. Microbiol. 13 1991 58 61
45. M.E. Katsarou, E.K. Efthimiadou, G. Psomas, A. Karaliota, and D. Vourloumis Novel copper(II) complex of N-propyl-norfloxacin and 1,10-phenanthroline with enhanced antileukemic and DNA nuclease activities J. Med. Chem. 51 2008 470 478 (Pubitemid 351252275)
46. J. Gong, X. Li, F. Traganos, and Z. Darzynkiewicz Expression of G(1) and G(2) cyclins measured in individual cells by multiparameter flow-cytometry - a new tool in the analysis of the cell-cycle Cell Prolif. 27 1994 357 371
47. E.I. Montero, S. Diaz, A.M. Gonzalez-Vadillo, J.M. Perez, C. Alonso, and C. Navarro-Ranninger Preparation and characterization of novel trans-[PtCl(2)(amine)(isopropylamine)] compounds: cytotoxic activity and apoptosis induction in ras-transformed cells J. Med. Chem. 42 1999 4264 4268 (Pubitemid 29483044)
48. R. Csuk, S. Schwarz, B. Siewert, R. Kluge, and D. Ströhl Synthesis and antitumor activity of ring A modified glycyrrhetinic acid derivatives Eur. J. Med. Chem. 46 2011 5356 5369
49. M. Roberti, D. Pizzirani, D. Simoni, R. Rondanin, R. Baruchello, C. Bonora, F. Buscemi, S. Grimaudo, and M. Tolomeo Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents J. Med. Chem. 46 2003 3546 3554 (Pubitemid 36909831)
50. M.Z. Gao, M. Wang, K.D. Miller, G.W. Sledge, G.D. Hutchins, and Q.H. Zheng Synthesis of radiolabeled stilbene derivatives as new potential PET probes for aryl hydrocarbon receptor in cancers Bioorg. Med. Chem. Lett. 16 2006 5767 5772 (Pubitemid 44486747)
51. S. Kim, H. Ko, J.E. Park, S. Jung, S.K. Lee, and Y.J. Chun Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P4501B1 inhibitors J. Med. Chem. 45 2002 160 164 (Pubitemid 34038551)
52. L. Botella, and C. Najera Synthesis of methylated resveratrol and analogues by Heck reactions in organic and aqueous solvents Tetrahedron 60 2004 5563 5570 (Pubitemid 38759336)
53. V. Roldos, H. Nakayama, M. Rolon, A. Montero-Torres, F. Trucco, S. Torres, C. Vega, Y. Marrero-Ponce, V. Heguaburu, G. Yaluff, A. Gomez-Barrio, L. Sanabria, M.E. Ferreira, A.R. de Arias, and E. Pandolfi Activity of a hydroxybibenzyl bryophyte constituent against Leishmania spp. and Trypanosoma cruzi: in silico, in vitro and in vivo activity studies Eur. J. Med. Chem. 43 2008 1797 1807
54. J.J. Heynekamp, W.M. Weber, L.A. Hunsaker, A.M. Gonzales, R.A. Orlando, L.M. Deck, and D.L.V. Jagt Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor KappaB J. Med. Chem. 49 2006 7182 7189 (Pubitemid 44886003)
55. W. Zhang, and M.L. Go Quinone reductase induction activity of methoxylated analogues of resveratrol Eur. J. Med. Chem. 42 2007 841 850 (Pubitemid 46810071)
56. R.J. Kumar, D. Jyostna, G.L.D. Krupadanam, and G. Srimannarayana Phenanthrene and stilbenes from pterolobium-hexapetallum Phytochemistry 27 1988 3625 3626
57. J. Smidrkal, J. Harmatha, M. Budesinsky, K. Vokac, Z. Zidek, E. Kmonickova, R. Merkl, and V. Filip Modified approach for preparing (E)-Stilbenes related to resveratrol, and evaluation of their potential immunobiological effects Collect. Czech. Chem. Commun. 75 2010 175 186
58. G. Belofsky, D. Percivill, K. Lewis, G.P. Tegos, and J. Ekart Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria J. Nat. Prod. 67 2004 481 484 (Pubitemid 38405723)
59. E. Kato, Y. Tokunaga, and F. Sakan Stilbenoids isolated from the seeds of Melinjo (Gnetum gnemon L.) and their biological activity J. Agr. Food Chem. 57 2009 2544 2549
60. E. Malan, E. Swinny, D. Ferreira, and A.J. Hall Metabolites from Chlorophora-excelsa - possible intermediates in the biogenesis of a pentasubstituted stilbene Phytochemistry 27 1988 2309 2312
61. J. McNulty, and P. Das Highly stereoselective and general synthesis of (E)-stilbenes and alkenes by means of an aqueous Wittig reaction Eur. J. Org. Chem. 2009 4031 4035
62. K.S. Huang, Y.H. Wang, R.L. Li, and M. Lin Five new stilbene dimers from the lianas of Gnetum hainanense J. Nat. Prod. 63 2000 86 89 (Pubitemid 30078775)